LOS ANGELES, CALIF. – (July 1, 2026) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, proudly announces new appointments to ...
Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...
Pancreatic cancer is advanced when it is unresectable, or can’t be removed by surgery. The cancer has spread to nearby blood vessels or lymph nodes, somewhat outside the pancreas or to distant organs ...
For the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma, more than 90% of tumors are thought to have a KRAS mutation. For decades, these mutations were considered “undruggable, ...
LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...
The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI). In response, and as Congress returns to ...
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...
July 1, 2021 marks 30 years since the beloved actor, writer and director Michael Landon – best known for playing Little Joe Cartwright on “Bonanza,” Charles (Pa) Ingalls on “Little House on the ...
Pancreatic cancer at any stage can create challenges in a patient’s diet and change nutritional needs. In recognition of June as National Fresh Fruit and Vegetable Month, we asked Maria Petzel, senior ...
Editor’s note: It’s been 12 years since the passing of Steve Jobs. This blog, published two years ago, discusses the rare form of pancreatic cancer Jobs had, pancreatic neuroendocrine tumor. It’s been ...
FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know
For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results